DK0565862T3 - Semisyntetiske glucosaminoglycaner, der i 3-stillingen indeholder med nukleofile radikaler substitueret alfa-L-galacturonsyre - Google Patents

Semisyntetiske glucosaminoglycaner, der i 3-stillingen indeholder med nukleofile radikaler substitueret alfa-L-galacturonsyre

Info

Publication number
DK0565862T3
DK0565862T3 DK93103847.5T DK93103847T DK0565862T3 DK 0565862 T3 DK0565862 T3 DK 0565862T3 DK 93103847 T DK93103847 T DK 93103847T DK 0565862 T3 DK0565862 T3 DK 0565862T3
Authority
DK
Denmark
Prior art keywords
galacturonic acid
glucosaminoglycans
semisynthetic
alpha
radicals substituted
Prior art date
Application number
DK93103847.5T
Other languages
English (en)
Inventor
Egidio Marchi
Silvano Piani
Gianfranco Tamagnone
Fabrizio Ungarelli
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Application granted granted Critical
Publication of DK0565862T3 publication Critical patent/DK0565862T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK93103847.5T 1992-04-17 1993-03-10 Semisyntetiske glucosaminoglycaner, der i 3-stillingen indeholder med nukleofile radikaler substitueret alfa-L-galacturonsyre DK0565862T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO920140A IT1260136B (it) 1992-04-17 1992-04-17 Glicosaminoglicani semisintetici contenenti acido alfa-l-galatturonicosostituito con radicali nucleofili in posizione 3

Publications (1)

Publication Number Publication Date
DK0565862T3 true DK0565862T3 (da) 1997-12-15

Family

ID=11338174

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93103847.5T DK0565862T3 (da) 1992-04-17 1993-03-10 Semisyntetiske glucosaminoglycaner, der i 3-stillingen indeholder med nukleofile radikaler substitueret alfa-L-galacturonsyre

Country Status (18)

Country Link
US (1) US5430132A (da)
EP (1) EP0565862B1 (da)
JP (1) JP2702377B2 (da)
KR (1) KR0171623B1 (da)
AT (1) ATE154615T1 (da)
AU (1) AU658499B2 (da)
CA (1) CA2093148C (da)
DE (1) DE69311618T2 (da)
DK (1) DK0565862T3 (da)
ES (1) ES2103991T3 (da)
FI (1) FI106555B (da)
GR (1) GR3024582T3 (da)
IL (1) IL105111A (da)
IT (1) IT1260136B (da)
NO (1) NO306305B1 (da)
NZ (1) NZ247197A (da)
TW (1) TW229213B (da)
ZA (1) ZA931799B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1260137B (it) * 1992-04-17 1996-03-28 Alfa Wassermann Spa Glicosaminoglicani semisintetici a struttura eparinica od eparanica modificati nella posizione 2 dell'acido alfa-l-iduronico-2-0-solfato
US5696100A (en) * 1992-12-22 1997-12-09 Glycomed Incorporated Method for controlling O-desulfation of heparin and compositions produced thereby
IT1264102B1 (it) * 1993-03-29 1996-09-10 Alfa Wassermann Spa Processo per la sintesi di glicosaminoglicani semisintetici contenenti acido alfa-l-galatturonico sostituito con radicali
IT1264101B1 (it) * 1993-03-29 1996-09-10 Alfa Wassermann Spa Processo per la sintesi di glicosaminoglicani semisintetici a struttura eparinica od eparanica modificati nella posizione 2
US5583121A (en) * 1994-01-12 1996-12-10 Michigan State University Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
US6127347A (en) * 1994-01-12 2000-10-03 Univ Michigan Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
NO984143L (no) 1998-09-09 2000-03-10 Norsk Hydro As Ny prosess for å fremstille overflatemodifiserende stoffer
EP1192187A1 (en) * 1999-06-30 2002-04-03 Hamilton Civic Hospitals Research Development, Inc. Heparin compositions that inhibit clot associated coagulation factors
US7259152B2 (en) 2000-06-07 2007-08-21 Alfa Wasserman, Inc. Methods and compositions using sulodexide for the treatment of diabetic nephropathy
CZ2003961A3 (cs) * 2000-09-08 2003-10-15 Hamilton Civic Hospitals Research Development, Inc. Farmaceutický prostředek k inhibici nebo prevenci tvorby či aktivity thrombinu
JP4828795B2 (ja) 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
EP2526122B1 (en) * 2010-01-19 2020-06-10 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
JPWO2012036152A1 (ja) * 2010-09-14 2014-02-03 国立大学法人 宮崎大学 高純度ヘパリンおよびその製造方法
US9068957B2 (en) 2011-02-21 2015-06-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
JP7401882B2 (ja) * 2016-03-09 2023-12-20 株式会社糖鎖工学研究所 硫酸基を有する糖の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987223A (en) * 1981-12-23 1991-01-22 Choay S.A. Derivatives of the uronic acid
IT1234508B (it) * 1988-06-10 1992-05-19 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
DE3821271A1 (de) * 1988-06-23 1989-12-28 Solco Basel Ag Derivatisiertes heparin, verfahren zu dessen herstellung und arzneimittel, welches dieses enthaelt
IT1234826B (it) * 1989-01-30 1992-05-29 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
US5200523A (en) * 1990-10-10 1993-04-06 Monsanto Company Synthesis of nojirimycin derivatives

Also Published As

Publication number Publication date
FI931740A0 (fi) 1993-04-16
DE69311618T2 (de) 1997-12-11
ITBO920140A0 (it) 1992-04-17
CA2093148C (en) 1999-01-26
FI106555B (fi) 2001-02-28
NZ247197A (en) 1995-02-24
NO931181L (no) 1993-10-18
GR3024582T3 (en) 1997-12-31
TW229213B (da) 1994-09-01
ZA931799B (en) 1993-12-27
DE69311618D1 (de) 1997-07-24
EP0565862B1 (en) 1997-06-18
AU3689693A (en) 1993-10-21
KR0171623B1 (ko) 1999-02-01
ITBO920140A1 (it) 1993-10-17
NO306305B1 (no) 1999-10-18
IT1260136B (it) 1996-03-28
KR930021651A (ko) 1993-11-22
JPH0616704A (ja) 1994-01-25
US5430132A (en) 1995-07-04
ES2103991T3 (es) 1997-10-01
FI931740A (fi) 1993-10-18
JP2702377B2 (ja) 1998-01-21
ATE154615T1 (de) 1997-07-15
CA2093148A1 (en) 1993-10-18
EP0565862A2 (en) 1993-10-20
IL105111A (en) 1997-03-18
AU658499B2 (en) 1995-04-13
NO931181D0 (no) 1993-03-30
EP0565862A3 (en) 1993-11-10

Similar Documents

Publication Publication Date Title
DK0565862T3 (da) Semisyntetiske glucosaminoglycaner, der i 3-stillingen indeholder med nukleofile radikaler substitueret alfa-L-galacturonsyre
NO305992B1 (no) Halvsyntetiske glykosaminglykosaner med heparin- eller heparanstruktur og fremgangsmåte til fremstilling derav
FI920430A (fi) Benzyloxifenylderivator.
GR3024710T3 (en) Process for the synthesis of semisynthetic glycosaminoglycans containig alpha-L-galacturonic acid substituted with nucleophilic radicals in position 3.
NO941128D0 (no) Fremgangsmåte til syntese av semisyntetiske glukosaminoglykaner med heparin eller en heparinstruktur modifisert i 2-posisjon av